Doctors battling the deadly Bundibugyo strain in DR Congo will likely have to wait months for a vaccine.

Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the Democratic Republic of the Congo and Uganda.

The outbreak is only the third caused by the rare Bundibugyo virus, for which there are no approved vaccines or therapeutics.

Cases set to increase, WHO warns, with infections appearing in urban centres and neighbouring Uganda